Back to Journals » Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy » Volume 12

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy


Archive: Volume 12, 2019

Relationship Between Skeletal Muscle Mass Indexes and Muscular Function, Metabolic Profile and Bone Mineral Density in Women with Recommendation for Bariatric Surgery

Crispim Carvalho NN, Baccin Martins VJ, Modesto Filho J, Bandeira F, Fernandes Pimenta FC, de Brito Alves JL

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2645-2654

Published Date: 12 December 2019

Ursolic Acid Treatment Alleviates Diabetic Kidney Injury By Regulating The ARAP1/AT1R Signaling Pathway

Ma TK, Xu L, Lu LX, Cao X, Li X, Li LL, Wang X, Fan QL

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2597-2608

Published Date: 9 December 2019

Vitamin B12 Deficiency and Foot Ulcers in Type 2 Diabetes Mellitus: A Case–Control Study

Badedi M, Darraj H, Hummadi A, Solan Y, Zakri I, Khawaji A, Daghreeri M, Budaydi A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2589-2596

Published Date: 6 December 2019

Dynamics of Epicardiac Fat and Heart Function in Type 2 Diabetic Patients Initiated with SGLT-2 Inhibitors

Braha A, Timar B, Diaconu L, Lupusoru R, Vasiluta L, Sima A, Vlad A, Munteanu M, Albai A, Cipu D, Timar R

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2559-2566

Published Date: 5 December 2019

Type 1 Diabetes and Bone Fragility: Links and Risks

Starup-Linde J, Hygum K, Harsløf T, Langdahl B

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2539-2547

Published Date: 3 December 2019

Urinary C-Peptide Creatinine Ratio as a Non-Invasive Tool for Identifying Latent Autoimmune Diabetes in Adults (LADA)

Liu W, Huang X, Zhang X, Cai X, Han X, Zhou X, Chen L, Zhang R, Gong S, Wang Y, Ji L

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2531-2537

Published Date: 2 December 2019

The Effects of Type 2 Diabetes and Postoperative Pneumonia on the Mortality in Inpatients with Surgery

Ma C, Liu Q, Li M, Ji M, Zhang J, Zhang B, Yin FZ

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2507-2513

Published Date: 29 November 2019

TeDia - A Telemedicine-Based Treatment Model for Inpatient and Interprofessional Diabetes Care

Röhling M, Redaélli M, Simic D, Lorrek K, Samel C, Schneider P, Kempf K, Stock S, Martin S

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2479-2487

Published Date: 29 November 2019

Slowly Progressive Type 1 Diabetes Mellitus: Current Knowledge And Future Perspectives

Nishimura A, Matsumura K, Kikuno S, Nagasawa K, Okubo M, Mori Y, Kobayashi T

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2461-2477

Published Date: 28 November 2019

TNF-α (−308) Gene Polymorphism and Type 2 Diabetes Mellitus in Ethiopian Diabetes Patients

Ayelign B, Genetu M, Wondmagegn T, Adane G, Negash M, Berhane N

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2453-2459

Published Date: 28 November 2019

Clinic, Anthropometric And Metabolic Changes In Adults With Class III Obesity Classified As Metabolically Healthy And Metabolically Unhealthy

Loureiro LM, Cordeiro A, Mendes R, Luna M, Pereira S, Saboya CJ, Ramalho A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2419-2431

Published Date: 27 November 2019

Hepatic Steatosis Index Is Associated with Type 1 Diabetes Complications

Tripolino C, Irace C, Cutruzzolà A, Parise M, Barone M, Scicchitano C, Cortese C, Gnasso A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2405-2410

Published Date: 20 November 2019

The Impact Of Structured Exercise Programs On Metabolic Syndrome And Its Components: A Systematic Review

Joseph MS, Tincopa MA, Walden P, Jackson E, Conte ML, Rubenfire M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2395-2404

Published Date: 18 November 2019

The Association Between Normal BMI With Central Adiposity And Proinflammatory Potential Immunoglobulin G N-Glycosylation

Liu D, Li Q, Dong J, Li D, Xu X, Xing W, Zhang X, Cao W, Hou H, Wang H, Song M, Tao L, Kang X, Meng Q, Wang W, Guo X, Wang Y

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2373-2385

Published Date: 14 November 2019

Increased Risk Of Type 2 Diabetes And Abnormal FPG Due To Shift Work Differs According To Gender: A Retrospective Cohort Study Among Thai Workers In Bangkok, Thailand

Hanprathet N, Lertmaharit S, Lohsoonthorn V, Rattananupong T, Ammaranond P, Jiamjarasrangsi W

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2341-2354

Published Date: 12 November 2019

Cdc42 Promotes ADSC-Derived IPC Induction, Proliferation, And Insulin Secretion Via Wnt/β-Catenin Signaling

Xiao XH, Huang QY, Qian XL, Duan J, Jiao XQ, Wu LY, Huang QY, Li J, Lai XN, Shi YB, Xiong LX

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2325-2339

Published Date: 13 November 2019

Polymorphism Of The APM1 Gene In Subjects With Central Obesity Related To Lower High-Density Lipoprotein Cholesterol

Barliana MI, Yolanda PD, Rostinawati T, Ng H, Alfian SD, Abdulah R, Diantini A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2317-2324

Published Date: 6 November 2019

The Role Of Adiponectin, TNF-α And Glutathione In The Pathogenesis And Evolution Of Type 1 Diabetes

Szabo CE, Ilieș RF, Aioanei CS, Catana A, Creț V, Șerban RS, Pop IV

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2303-2308

Published Date: 5 November 2019

The Characteristics Of Abdominal Fat Distribution In Japanese Adolescents With Type 2 Diabetes Mellitus

Abe Y, Urakami T, Hara M, Yoshida K, Mine Y, Aoki M, Suzuki J, Saito E, Yoshino Y, Iwata F, Okada T, Morioka I

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2281-2288

Published Date: 1 November 2019

Effects Of PPARγ2 Pro12Ala Variant On Adipocyte Phenotype Dependent Of DHA

Wan R, Ding Z, Xia S, Zheng L, Lu J

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2273-2279

Published Date: 1 November 2019

Mitigating The Burden Of Diabetes In Sub-Saharan Africa Through An Integrated Diagonal Health Systems Approach

Mercer T, Chang AC, Fischer L, Gardner A, Kerubo I, Tran DN, Laktabai J, Pastakia S

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2261-2272

Published Date: 31 October 2019

The Epidemic Of The Metabolic Syndrome Among The Palestinians In The Gaza Strip

Jamee AS, Aboyans V, Magne J, Preux PM, Lacroix P

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2201-2208

Published Date: 22 October 2019

Can Low SHBG Serum Concentration Be A Good Early Marker Of Male Hypogonadism In Metabolic Syndrome?

Jarecki P, Herman WA, Pawliczak E, Lacka K

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2181-2191

Published Date: 21 October 2019

AdipoRon Alleviates Free Fatty Acid-Induced Myocardial Cell Injury Via Suppressing Nlrp3 Inflammasome Activation

Zhang YZ, Zhang YL, Huang Q, Huang C, Jiang ZL, Cai F, Shen JF

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2165-2179

Published Date: 23 October 2019

Lymphocyte To High-Density Lipoprotein Ratio As A New Indicator Of Inflammation And Metabolic Syndrome

Chen H, Xiong C, Shao X, Ning J, Gao P, Xiao H, Chen Y, Zou Z, Hong G, Li X, Shao M, Sheng J, Yang X, You X, Zou H

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2117-2123

Published Date: 14 October 2019

Effects Of Saffron Supplementation On Inflammation And Metabolic Responses In Type 2 Diabetic Patients: A Randomized, Double-Blind, Placebo-Controlled Trial

Ebrahimi F, Sahebkar A, Aryaeian N, Pahlavani N, Fallah S, Moradi N, Abbasi D, Hosseini AF

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2107-2115

Published Date: 14 October 2019

Metabolic Syndrome Is Associated With Rapid Estimated Glomerular Filtration Rate Decline In A Chinese Community-Based Population

Wu Z, Jiang Y, Jia J, He D, Sun P, Li J, Huo Y, Fan F, Zhang Y

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2085-2093

Published Date: 11 October 2019

A Novel Indicator Of Lipid Accumulation Product Associated With Metabolic Syndrome In Chinese Children And Adolescents

Zhang Y, Hu J, Li Z, Li T, Chen M, Wu L, Liu W, Han H, Yao R, Fu L

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2075-2083

Published Date: 10 October 2019

Genistein diet improves body weight, serum glucose and triglyceride levels in both male and female ob/ob mice

Rockwood S, Mason D, Lord R, Lamar P, Prozialeck W, Al-Nakkash L

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2011-2021

Published Date: 3 October 2019

The Impact Of Hyperuricemia On Cardiometabolic Risk Factors In Patients With Diabetes Mellitus: A Cross-Sectional Study

Gaita L, Timar R, Lupascu N, Roman D, Albai A, Potre O, Timar B

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2003-2010

Published Date: 3 October 2019

Potential role of phytochemicals in metabolic syndrome prevention and therapy

Francini-Pesenti F, Spinella P, Calò LA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1987-2002

Published Date: 1 October 2019

Multivariable Logistic Regression And Back Propagation Artificial Neural Network To Predict Diabetic Retinopathy

Yao L, Zhong Y, Wu J, Zhang G, Chen L, Guan P, Huang D, Liu L

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1943-1951

Published Date: 25 September 2019

NLRP3 inflammasome promotes diabetes-induced endothelial inflammation and atherosclerosis

Wan Z, Fan Y, Liu X, Xue J, Han Z, Zhu C, Wang X

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1931-1942

Published Date: 20 September 2019

Serum CTRP3 Levels In Obese Children: A Potential Protective Adipokine Of Obesity, Insulin Sensitivity And Pancreatic β Cell Function

Chen T, Wang F, Chu Z, Shi X, Sun L, Lv H, Zhou W, Shen J, Chen L, Hou M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1923-1930

Published Date: 20 September 2019

Burden Of Treatment Among Patients Undergoing Intravitreal Injections For Diabetic Macular Oedema In Australia

Spooner KL, Guinan G, Koller S, Hong T, Chang AA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1913-1921

Published Date: 19 September 2019

A spotlight on alirocumab in high cardiovascular risk patients with type 2 diabetes and mixed dyslipidemia: a review on the emerging data

Rana K, Reid J, Rosenwasser JN, Lewis T, Sheikh-Ali M, Choksi RR, Goldfaden RF

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1897-1911

Published Date: 19 September 2019

Does a diabetic retinopathy educational program raise awareness among elderly diabetic patients?

Khalaf FR, Fahmy HM, Ibrahim AK, Mohamed GA, El Sayed Ez Eldeen M, Elkady A, Hetta HF

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1867-1875

Published Date: 20 September 2019

Lifestyle intervention for obesity: a call to transform the clinical care delivery system in Mexico

Díaz-Zavala RG, Candia-Plata MC, Martínez-Contreras TJ, Esparza-Romero J

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1841-1859

Published Date: 13 September 2019

Influence of genomic ancestry and self-reported color-race in CKD in a nationwide admixed sample of Brazilian patients with type 1 diabetes

Pizarro MH, Santos DC, Melo LGN, Barros BSV, Muniz LH, Porto LC, Silva DA, Gomes MB

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1831-1840

Published Date: 12 September 2019

Calpain-10 drives podocyte apoptosis and renal injury in diabetic nephropathy

Wang T, Gao Y, Wang X, Shi Y, Xu J, Wu B, He J, Li Y

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1811-1820

Published Date: 11 September 2019

Anthropometric variables as cardiovascular risk predictors in a cohort of adult subjects with Turner syndrome

Álvarez-Nava F, Racines M, Witt J, Guarderas J, Estévez M, Lanes R

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1795-1809

Published Date: 9 September 2019

High-fat diet-induced kidney alterations in rats with metabolic syndrome: endothelial dysfunction and decreased antioxidant defense

Rangel Silvares R, Nunes Goulart da Silva Pereira E, Eduardo Ilaquita Flores E, Lino Rodrigues K, Ribeiro Silva A, Gonçalves-de-Albuquerque CF, Daliry A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1773-1781

Published Date: 6 September 2019

Association between new anthropometric parameters and arterial stiffness based on brachial-ankle pulse wave velocity

Choi HS, Cho YH, Lee SY, Park EJ, Kim YJ, Lee JG, Yi YH, Tak YJ, Hwang HR, Lee SH

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1727-1733

Published Date: 3 September 2019

Effect of berberine on the HPA-axis pathway and skeletal muscle GLUT4 in type 2 diabetes mellitus rats

Mi J, He W, Lv J, Zhuang K, Huang H, Quan S

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1717-1725

Published Date: 3 September 2019

Effects of liraglutide on lipolysis and the AC3/PKA/HSL pathway

Li Z, Yang P, Liang Y, Xia N, Li Y, Su H, Pan H

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1697-1703

Published Date: 3 September 2019

Comparison of self-care in non-cardiac diabetic patients

Asghari F, Nobahar M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1675-1683

Published Date: 2 September 2019

Correlation analysis of metabolic syndrome and its components with thyroid nodules

Liu J, Wang C, Tang X, Fu S, Jing G, Ma L, Sun W, Li Y, Wu D, Niu Y, Niu Q, Guo H, Song P

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1617-1623

Published Date: 30 August 2019

Regulation of alternative splicing in obesity-induced hypertension

Dlamini Z, Hull R, Makhafola TJ, Mbele M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1597-1615

Published Date: 28 August 2019

The effect of A1 adenosine receptor in diabetic megalin loss with caspase-1/IL18 signaling

Tian D, Shi X, Zhao Y, Peng X, Zou L, Xu L, Ma Y, Wen Y, Faulhaber-Walter R, Chen L

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1583-1596

Published Date: 28 August 2019

Association between serum TSH levels and metabolic components in euthyroid subjects: a nationwide population-based study

Ren R, Ma Y, Deng F, Li T, Wang H, Wei J, Jiang X, He M, Tian M, Liu D, Chen B, Deng W

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1563-1569

Published Date: 22 August 2019

Empagliflozin in type 1 diabetes

Mathieu C, Van Den Mooter L, Eeckhout B

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1555-1561

Published Date: 22 August 2019

Prevalence and identification of type 1 diabetes in Chinese adults with newly diagnosed diabetes

Tang X, Yan X, Zhou H, Yang X, Niu X, Liu J, Ji Q, Ji L, Li X, Zhou Z

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1527-1541

Published Date: 28 August 2019

Impact of arterial hypertension and type 2 diabetes on cardiac autonomic modulation in obese individuals with recommendation for bariatric surgery

Carvalho NNC, de Oliveira Junior FA, da Silva G, Baccin Martins VJ, Braga VA, Costa-Silva JH, Fernandes Pimenta FC, de Brito Alves JL

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1503-1511

Published Date: 21 August 2019

Aging-associated impairment in metabolic compensation by subcutaneous adipose tissue promotes diet-induced fatty liver disease in mice

Taketani H, Nishikawa T, Nakajima H, Kodo K, Sugimoto S, Aoi W, Horike S, Meguro-Horike M, Ishiba H, Seko Y, Umemura A, Yamaguchi K, Moriguchi M, Yasui K, Itoh Y

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1473-1492

Published Date: 23 August 2019

The relationship of mitochondrial dysfunction and the development of insulin resistance in Cushing’s syndrome

Ježková J, Ďurovcová V, Wenchich L, Hansíková H, Zeman J, Hána V, Marek J, Lacinová Z, Haluzík M, Kršek M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1459-1471

Published Date: 19 August 2019

Association of diabetes knowledge with glycemic control and self-care practices among Pakistani people with type 2 diabetes mellitus

Bukhsh A, Khan TM, Sarfraz Nawaz M, Sajjad Ahmed H, Chan KG, Goh BH

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1409-1417

Published Date: 14 August 2019

Real-world insulin therapy in German type 2 diabetes mellitus patients: patient characteristics, treatment patterns, and insulin dosage [Corrigendum]

Wilke T, Picker N, Mueller S, Geier S, Foersch J, Aberle J, Martin S, Riedl M, Gabler M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1397-1398

Published Date: 14 August 2019

Urinary biomarkers for diagnosing poststroke depression in patients with type 2 diabetes mellitus

Liang ZH, Jia YB, Li ZR, Li M, Wang ML, Yun YL, Yu LJ, Shi L, Zhu RX

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1379-1386

Published Date: 13 August 2019

Ambient air pollution exposure and obesity-related traits in Korean adults

Hwang SE, Kwon H, Jeong SM, Kim HJ, Park JH

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1365-1377

Published Date: 9 August 2019

2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione isolated from Averrhoa carambola L. root ameliorates diabetic nephropathy by inhibiting the TLR4/MyD88/NF-κB pathway

Lu S, Zhang H, Wei X, Huang X, Chen L, Jiang L, Wu X, Zhou X, Qin L, Li Y, Lin X, Huang R

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1355-1363

Published Date: 7 August 2019

The barriers against initiating insulin therapy among patients with diabetes living in Yazd, Iran

Shafie Pour MR, Sadeghiyeh T, Hadavi M, Besharati M, Bidaki R

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1349-1354

Published Date: 7 August 2019

Impact of Ginkgo biloba extract and magnetized water on the survival rate and functional capabilities of pancreatic β-cells in type 2 diabetic rat model

Saleh A, Anwar MM, Zayed AE, Ezz Eldeen MES, Afifi G, Alnashiri HM, Gomaa AMS, Abd-Elkareem M, Abou-Elhamd AS, Shaheen ES, Mohamed GA, Hetta HF, Kotb AM

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1339-1347

Published Date: 7 August 2019

Correlation of acidosis-adjusted potassium level and cardiovascular outcomes in diabetic ketoacidosis: a systematic review

Usman A, Makmor Bakry M, Mustafa N, Rehman IU, Bukhsh A, Lee SWH, Khan TM

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1323-1338

Published Date: 6 August 2019

Empowerment of patients with type 2 diabetes: current perspectives

Gómez-Velasco DV, Almeda-Valdes P, Martagón AJ, Galán-Ramírez GA, Aguilar-Salinas CA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1311-1321

Published Date: 6 August 2019

mRNAs expression profiles of high glucose-induced memory in human umbilical vein endothelial cells

Jin G, Wang Q, Pei X, Li X, Hu X, Xu E, Li M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1249-1261

Published Date: 23 July 2019

Real-world insulin therapy in German type 2 diabetes mellitus patients: patient characteristics, treatment patterns, and insulin dosage

Wilke T, Picker N, Mueller S, Geier S, Foersch J, Aberle J, Martin S, Riedl M, Gabler M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1225-1237

Published Date: 24 July 2019

Diabetes care in public health facilities in India: a situational analysis using a mixed methods approach

Tripathy JP, Sagili KD, Kathirvel S, Trivedi A, Nagaraja SB, Bera OP, Reddy KK, Satyanarayana S, Khanna A, Chadha SS

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1189-1199

Published Date: 19 July 2019

A cross-sectional study of risk factors and hypertension among adolescent Senior High School students

Amponsem-Boateng C, Zhang W, Oppong TB, Opolot G, Kumi Duodu Kyere E

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1173-1180

Published Date: 24 July 2019

Osteoarthritis patients with high haemoglobin A1c have increased Toll-like receptor 4 and matrix metalloprotease-13 expression in the synovium

Murata K, Uchida K, Takano S, Shoji S, Iwase D, Inoue G, Aikawa J, Yokozeki Y, Sekiguchi H, Takaso M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1151-1159

Published Date: 16 July 2019

Ginsenoside Rg1 ameliorates cardiac oxidative stress and inflammation in streptozotocin-induced diabetic rats

Qin Q, Lin N, Huang H, Zhang X, Cao X, Wang Y, Li P

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1091-1103

Published Date: 10 July 2019

Smoking results in accumulation of ectopic fat in the liver

Kato A, Li Y, Ota A, Naito H, Yamada H, Nihashi T, Hotta Y, Chiang C, Hirakawa Y, Aoyama A, Tamakoshi K, Yatsuya H

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1075-1080

Published Date: 9 July 2019

Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship

Mesinovic J, Zengin A, De Courten B, Ebeling PR, Scott D

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1057-1072

Published Date: 8 July 2019

Metabolic syndrome is associated with peripheral endothelial dysfunction amongst men

Taher R, Sara JD, Heidari B, Toya T, Lerman LO, Lerman A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1035-1045

Published Date: 5 July 2019

Liraglutide ameliorates nonalcoholic fatty liver disease in diabetic mice via the IRS2/PI3K/Akt signaling pathway

Yang P, Liang Y, Luo Y, Li Z, Wen Y, Shen J, Li R, Zheng H, Gu HF, Xia N

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1013-1021

Published Date: 4 July 2019

Optimal management of diabetic foot osteomyelitis: challenges and solutions

Lázaro Martínez JL, García Álvarez Y, Tardáguila-García A, García Morales E

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:947-959

Published Date: 21 June 2019

Higher blood pressure increases arterial stiffness modified by blood glucose levels in a Chinese community-based study

Dai X, Yang Y, Cheng GL, Jia J, Fan FF, Li JP, Huo Y, Liu Z, Chen D, Zhang Y

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:901-911

Published Date: 24 June 2019

Obesity, adipocyte hypertrophy, fasting glucose, and resistin are potential contributors to nonalcoholic fatty liver disease in South Asian women

Albracht-Schulte K, Rosairo S, Ramalingam L, Wijetunge S, Ratnayake RMCJ, Kotakadeniya HMSRB, Dawson JA, Kalupahana NS, Moustaid-Moussa N

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:863-872

Published Date: 10 June 2019

Vitamin D deficiency and glycemic control among patients with type 2 diabetes mellitus in Jazan City, Saudi Arabia

Darraj H, Badedi M, Poore KR, Hummadi A, Khawaji A, Solan Y, Zakri I, Sabai A, Darraj M, Mutawwam DA, Daghreeri M, Sayed S, Alaallah W, Alfadhly A, Alsabaani A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:853-862

Published Date: 5 June 2019

Obesity: outcome of standardized life-style change in a rehabilitation clinic. An observational study

Haslacher H, Fallmann H, Waldhäusl C, Hartmann E, Wagner OF, Waldhäusl WK

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:813-820

Published Date: 27 May 2019

Assessment of insulin sensitivity and secretion in patients with fibrocalculous pancreatic diabetes

Aiswarya Y, Shivaprasad C, Anish K, Sridevi A, Anupam B, Amit G

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:779-788

Published Date: 22 May 2019

Early effects of roflumilast on insulin sensitivity in adults with prediabetes and overweight/obesity involve age-associated fat mass loss – results of an exploratory study

Muo IM, MacDonald SD, Madan R, Park SJ, Gharib AM, Martinez PE, Walter MF, Yang SB, Rodante JA, Courville AB, Walter PJ, Cai H, Glicksman M, Guerrieri GM, Ben-Dor RR, Ouwerkerk R, Mao S, Chung JH

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:743-759

Published Date: 27 May 2019

Immunogenetics of new onset diabetes after transplantation in Kuwait

Jahromi M, Al-Otaibi T, Othman N, Gheith O, Mahmoud T, Nair P, Halim MA, Nampoory N

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:731-742

Published Date: 20 May 2019

Prevalence of metabolic syndrome and its associated factors in Chinese patients with ankylosing spondylitis [Corrigendum]

Liu M, Huang Y, Huang Z, Huang Q, Guo X, Wang Y, Deng W, Huang Z, Li T

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:729-730

Published Date: 22 May 2019

The association of the fat mass and obesity-associated gene (FTO) rs9939609 polymorphism and the severe obesity in a Brazilian population

da Fonseca ACP, Abreu GM, Zembrzuski VM, Campos Junior M, Carneiro JRI, Nogueira Neto JF, Cabello GMK, Cabello PH

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:667-684

Published Date: 23 May 2019

An automatic diagnostic system based on deep learning, to diagnose hyperlipidemia

Zhang Q, Liu Y, Liu G, Zhao G, Qu Z, Yang W

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:637-645

Published Date: 3 May 2019

Potential role of circulating microRNAs (486-5p, 497, 509-5p and 605) in metabolic syndrome Egyptian male patients

Bakr Zaki M, Abulsoud AI, Elsisi AM, Doghish AS, Mansour OAE, Amin AI, Elrebehy MA, Mohamed MY, Goda MA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:601-611

Published Date: 6 May 2019

Barriers of medication adherence in patients with type-2 diabetes: a pilot qualitative study

Rezaei M, Valiee S, Tahan M, Ebtekar F, Ghanei Gheshlagh R

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:589-599

Published Date: 1 May 2019

The association between cardiac autonomic neuropathy and diabetes control

Vasheghani M, Sarvghadi F, Beyranvand MR

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:581-587

Published Date: 30 April 2019

Prevalence of metabolic syndrome in dialysis and transplant patients

AlShelleh S, AlAwwa I, Oweis A, AlRyalat SA, Al-Essa M, Saeed I, Alhawari HH, Alzoubi KH

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:575-579

Published Date: 29 April 2019

Anti-inflammatory and angiogenic effects of exercise training in cardiac muscle of diabetic mice

Broderick TL, Sennott JM, Gutkowska J, Jankowski M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:565-573

Published Date: 26 April 2019

Cystic fibrosis-related diabetes: optimizing care with a multidisciplinary approach

Frost F, Dyce P, Ochota A, Pandya S, Clarke T, Walshaw MJ, Nazareth DS

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:545-552

Published Date: 26 April 2019

Circulating microparticle subpopulation in metabolic syndrome: relation to oxidative stress and coagulation markers

Zahran AM, Sayed SK, Abd El Hafeez HA, Khalifa WA, Mohamed NA, Hetta HF

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:485-493

Published Date: 12 April 2019

Prevalence of metabolic syndrome and its associated factors in Chinese patients with ankylosing spondylitis

Liu M, Huang Y, Huang Z, Huang Q, Guo X, Wang Y, Deng W, Huang Z, Li T

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:477-484

Published Date: 11 April 2019

Prevalence of abnormal glucose homeostasis in Chinese patients with non-transfusion-dependent thalassemia

Luo Y, Bajoria R, Lai Y, Pan H, Li Q, Zhang Z, Yang P, Chatterjee R, Liang Y

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:457-468

Published Date: 11 April 2019

Low-dose computed tomography of urolithiasis in obese patients: a feasibility study to evaluate image reconstruction algorithms

Chang DH, Slebocki K, Khristenko E, Herden J, Salem J, Große Hokamp N, Mammadov K, Hellmich M, Kabbasch C

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:439-445

Published Date: 5 April 2019

Genetic variants linked to T2DM risk in Kurdish populations

Golsheh S, Keshavarzi F

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:431-437

Published Date: 5 April 2019

Neudesin in obesity and type 2 diabetes mellitus: the effect of acute fasting and weight reducing interventions

Kratochvilova H, Lacinova Z, Klouckova J, Kavalkova P, Cinkajzlova A, Trachta P, Krizova J, Benes M, Dolezalova K, Fried M, Vlasakova Z, Pelikanova T, Spicak J, Mraz M, Haluzik M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:423-430

Published Date: 28 March 2019

Resveratrol affects hepatic gluconeogenesis via histone deacetylase 4

Zhao H, Shu L, Huang W, Song G, Ma H

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:401-411

Published Date: 25 March 2019

Apelin and chemerin as promising adipokines in children with type 1 diabetes mellitus

Elsehmawy AAEW, El-Toukhy SE, Seliem NMA, Moustafa RS, Mohammed DS

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:383-389

Published Date: 22 March 2019

Increase in mast cell marker expression in the synovium of obese patients with osteoarthritis of the knee

Uchida K, Takano S, Inoue G, Iwase D, Aikawa J, Takata K, Tazawa R, Kawakubo A, Sekiguchi H, Takaso M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:377-382

Published Date: 21 March 2019

Galectin-3 as a prognostic biomarker for diabetic nephropathy

Hodeib H, Hagras MM, Abdelhai D, Watany MM, Selim A, Tawfik MA, Elsebaey MA, Elshweikh SA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:325-331

Published Date: 13 March 2019

Dietary patterns in relation to hepatic fibrosis among patients with nonalcoholic fatty liver disease

Soleimani D, Ranjbar G, Rezvani R, Goshayeshi L, Razmpour F, Nematy M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:315-324

Published Date: 12 March 2019

Measurement of diabetes, prediabetes and their associated risk factors in Myanmar 2014

Latt TS, Zaw KK, Ko K, Hlaing MM, Ohnmar M, Oo ES, Thein KMM, Yuasa M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:291-298

Published Date: 4 March 2019

Diabetic muscle infarction: often misdiagnosed and mismanaged

Verjee MA, Abdelsamad NA, Qureshi S, Malik RA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:285-290

Published Date: 5 March 2019

ATP-binding cassette transporter A1 (ABCA1) expression in adipose tissue and its modulation with insulin resistance in obesity

Vincent V, Thakkar H, Aggarwal S, Mridha AR, Ramakrishnan L, Singh A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:275-284

Published Date: 25 February 2019

Identification of the MC4R start lost mutation in a morbidly obese Brazilian patient

Fonseca ACP, Abreu GM, Zembrzuski VM, Campos Junior M, Carneiro JRI, Magno FCCM, Rosado EL, Nogueira Neto JF, Cabello GMK, Cabello PH

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:257-266

Published Date: 21 February 2019

Interaction between dietary patterns and TCF7L2 polymorphisms on type 2 diabetes mellitus among Uyghur adults in Xinjiang Province, China

Cai J, Zhang Y, Nuli R, Zhang Y, Abudusemaiti M, Kadeer A, Tian X, Xiao H

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:239-255

Published Date: 14 February 2019

PEARLS randomized lifestyle trial in pregnant Hispanic women with overweight/obesity: gestational weight gain and offspring birthweight

Trak-Fellermeier MA, Campos M, Meléndez M, Pomeroy J, Palacios C, Rivera-Viñas J, Méndez K, Febo I, Willett W, Gillman MW, Franks PW, Joshipura K

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:225-238

Published Date: 18 February 2019

Cardioprotective effects of a ruthenium (II) Schiff base complex in diet-induced prediabetic rats

Mabuza LP, Gamede MW, Maikoo S, Booysen IN, Ngubane PS, Khathi A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:217-223

Published Date: 14 February 2019

Canagliflozin review – safety and efficacy profile in patients with T2DM

Jakher H, Chang TI, Tan M, Mahaffey KW

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:209-215

Published Date: 1 February 2019

Leptin resistance: underlying mechanisms and diagnosis

Gruzdeva O, Borodkina D, Uchasova E, Dyleva Y, Barbarash O

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:191-198

Published Date: 25 January 2019

Analysis of the diet quality and dietary habits of children and adolescents with type 1 diabetes

Dłużniak-Gołaska K, Panczyk M, Szostak-Węgierek D, Szypowska A, Sińska B

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:161-170

Published Date: 17 January 2019

Elevated free fatty acid level is associated with insulin-resistant state in nondiabetic Chinese people

Xin YL, Wang Y, Chi J, Zhu X, Zhao H, Zhao S, Wang Y

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:139-147

Published Date: 17 January 2019

Metabolic syndrome as a risk factor for high intraocular pressure: the Korea National Health and Nutrition Examination Survey 2008–2010

Yi YH, Cho YH, Kim YJ, Lee SY, Lee JG, Kong EH, Cho BM, Tak YJ, Hwang HR, Lee SH, Park EJ

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:131-137

Published Date: 14 January 2019

Effects of omega-3 polyunsaturated fatty-acid supplementation on neuropathic pain symptoms and sphingosine levels in Mexican-Americans with type 2 diabetes

Durán AM, Salto LM, Câmara J, Basu A, Paquien I, Beeson WL, Firek A, Cordero-MacIntyre Z, De León M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:109-120

Published Date: 8 January 2019

Modulation of fat metabolism and gut microbiota by resveratrol on high-fat diet-induced obese mice

Campbell CL, Yu R, Li F, Zhou Q, Chen D, Qi C, Yin Y, Sun J

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:97-107

Published Date: 4 January 2019

Initial outcomes of one anastomosis gastric bypass at a single institution

Jamal W, Zagzoog MM, Sait SH, Alamoudi AO, Abo’ouf S, Alghamdi AA, Bamashmous RO, Maghrabi AA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:35-41

Published Date: 24 December 2018